next-generation therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Pep2Tango Therapeutics, backed by Versant Ventures, is redefining obesity treatment with next-gen peptide therapies targeting multiple receptors.

Read More

2 minute read

Pharma Industry News

Could this startup have the cure for obesity? Meet Pep2Tango Therapeutics!

Versant Ventures has introduced Pep2Tango Therapeutics Inc., a biotechnology startup dedicated to pioneering next-generation therapies for weight loss.…

byPallavi Madhiraju

November 23, 2024

web analytics